Ryan Zimmerman
Stock Analyst at BTIG
(4.23)
# 444
Out of 5,090 analysts
220
Total ratings
58.29%
Success rate
12%
Average return
Main Sectors:
Stocks Rated by Ryan Zimmerman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SOLV Solventum | Upgrades: Buy | $100 | $85.26 | +17.29% | 2 | Dec 2, 2025 | |
| ALC Alcon | Reiterates: Buy | $91 | $78.99 | +15.20% | 13 | Nov 24, 2025 | |
| HUMA Humacyte | Reiterates: Buy | $6 | $1.30 | +361.54% | 6 | Nov 21, 2025 | |
| GEHC GE HealthCare Technologies | Reiterates: Buy | $87 | $82.46 | +5.51% | 4 | Nov 21, 2025 | |
| ORGO Organogenesis Holdings | Maintains: Buy | $7 → $9 | $4.90 | +83.86% | 8 | Nov 20, 2025 | |
| RCEL AVITA Medical | Upgrades: Neutral | n/a | $3.54 | - | 4 | Nov 20, 2025 | |
| SYK Stryker | Reiterates: Buy | $410 | $364.35 | +12.53% | 18 | Nov 14, 2025 | |
| MDAI Spectral AI | Maintains: Buy | $3.5 → $3 | $1.70 | +76.47% | 2 | Nov 12, 2025 | |
| XTNT Xtant Medical Holdings | Maintains: Buy | $2 → $1.5 | $0.61 | +145.78% | 3 | Nov 11, 2025 | |
| TMCI Treace Medical Concepts | Downgrades: Neutral | n/a | $2.75 | - | 6 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $21 → $24 | $14.21 | +68.95% | 1 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $122 → $112 | $93.16 | +20.22% | 9 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $28 | $26.67 | +4.99% | 5 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $104 → $116 | $108.85 | +6.57% | 14 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $23 | $18.16 | +26.65% | 10 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $320 | $294.72 | +8.58% | 20 | Oct 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $529 → $589 | $568.65 | +3.58% | 21 | Oct 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $74.86 | - | 2 | Oct 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $190 → $195 | $181.60 | +7.38% | 1 | Oct 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $36.71 | - | 9 | Sep 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $35.68 | - | 2 | Sep 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $23 | $15.12 | +52.12% | 1 | Sep 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $145 → $148 | $125.40 | +18.02% | 7 | Jul 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $12.46 | - | 5 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $88.74 | - | 15 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | n/a | $13.55 | - | 6 | Oct 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $46 → $53 | $26.47 | +100.23% | 7 | Jul 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $3.00 | - | 3 | Nov 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $15.85 | - | 2 | Sep 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $195 → $200 | $141.96 | +40.88% | 1 | Apr 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $340 → $350 | $316.45 | +10.60% | 1 | Apr 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $138 → $128 | $101.99 | +25.50% | 4 | Dec 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $11.37 | +31.93% | 1 | Nov 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $42 | $18.07 | +132.43% | 1 | Sep 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $53 | $4.95 | +961.14% | 3 | Aug 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $32.82 | - | 3 | Apr 2, 2020 |
Solventum
Dec 2, 2025
Upgrades: Buy
Price Target: $100
Current: $85.26
Upside: +17.29%
Alcon
Nov 24, 2025
Reiterates: Buy
Price Target: $91
Current: $78.99
Upside: +15.20%
Humacyte
Nov 21, 2025
Reiterates: Buy
Price Target: $6
Current: $1.30
Upside: +361.54%
GE HealthCare Technologies
Nov 21, 2025
Reiterates: Buy
Price Target: $87
Current: $82.46
Upside: +5.51%
Organogenesis Holdings
Nov 20, 2025
Maintains: Buy
Price Target: $7 → $9
Current: $4.90
Upside: +83.86%
AVITA Medical
Nov 20, 2025
Upgrades: Neutral
Price Target: n/a
Current: $3.54
Upside: -
Stryker
Nov 14, 2025
Reiterates: Buy
Price Target: $410
Current: $364.35
Upside: +12.53%
Spectral AI
Nov 12, 2025
Maintains: Buy
Price Target: $3.5 → $3
Current: $1.70
Upside: +76.47%
Xtant Medical Holdings
Nov 11, 2025
Maintains: Buy
Price Target: $2 → $1.5
Current: $0.61
Upside: +145.78%
Treace Medical Concepts
Nov 7, 2025
Downgrades: Neutral
Price Target: n/a
Current: $2.75
Upside: -
Nov 7, 2025
Maintains: Buy
Price Target: $21 → $24
Current: $14.21
Upside: +68.95%
Nov 5, 2025
Maintains: Buy
Price Target: $122 → $112
Current: $93.16
Upside: +20.22%
Nov 4, 2025
Upgrades: Buy
Price Target: $28
Current: $26.67
Upside: +4.99%
Oct 30, 2025
Maintains: Buy
Price Target: $104 → $116
Current: $108.85
Upside: +6.57%
Oct 29, 2025
Reiterates: Buy
Price Target: $23
Current: $18.16
Upside: +26.65%
Oct 27, 2025
Reiterates: Buy
Price Target: $320
Current: $294.72
Upside: +8.58%
Oct 22, 2025
Maintains: Buy
Price Target: $529 → $589
Current: $568.65
Upside: +3.58%
Oct 21, 2025
Reiterates: Neutral
Price Target: n/a
Current: $74.86
Upside: -
Oct 13, 2025
Maintains: Buy
Price Target: $190 → $195
Current: $181.60
Upside: +7.38%
Sep 17, 2025
Downgrades: Neutral
Price Target: n/a
Current: $36.71
Upside: -
Sep 16, 2025
Reiterates: Neutral
Price Target: n/a
Current: $35.68
Upside: -
Sep 9, 2025
Reiterates: Buy
Price Target: $23
Current: $15.12
Upside: +52.12%
Jul 14, 2025
Maintains: Buy
Price Target: $145 → $148
Current: $125.40
Upside: +18.02%
Jul 9, 2025
Downgrades: Neutral
Price Target: n/a
Current: $12.46
Upside: -
May 27, 2025
Downgrades: Neutral
Price Target: n/a
Current: $88.74
Upside: -
Oct 7, 2024
Upgrades: Neutral
Price Target: n/a
Current: $13.55
Upside: -
Jul 15, 2024
Maintains: Buy
Price Target: $46 → $53
Current: $26.47
Upside: +100.23%
Nov 14, 2023
Downgrades: Neutral
Price Target: n/a
Current: $3.00
Upside: -
Sep 12, 2023
Downgrades: Neutral
Price Target: n/a
Current: $15.85
Upside: -
Apr 17, 2023
Maintains: Buy
Price Target: $195 → $200
Current: $141.96
Upside: +40.88%
Apr 17, 2023
Maintains: Buy
Price Target: $340 → $350
Current: $316.45
Upside: +10.60%
Dec 17, 2021
Maintains: Buy
Price Target: $138 → $128
Current: $101.99
Upside: +25.50%
Nov 22, 2021
Initiates: Buy
Price Target: $15
Current: $11.37
Upside: +31.93%
Sep 23, 2020
Initiates: Buy
Price Target: $42
Current: $18.07
Upside: +132.43%
Aug 14, 2020
Upgrades: Buy
Price Target: $53
Current: $4.95
Upside: +961.14%
Apr 2, 2020
Downgrades: Neutral
Price Target: n/a
Current: $32.82
Upside: -